Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 1
1970 1
1975 1
1978 1
1981 1
1984 3
1985 3
1986 6
1987 7
1988 3
1989 2
1990 1
1991 5
1992 7
1993 5
1994 1
1995 14
1996 5
1997 9
1998 8
1999 7
2000 8
2001 11
2002 8
2003 5
2004 10
2005 4
2006 9
2007 9
2008 8
2009 18
2010 14
2011 14
2012 21
2013 13
2014 17
2015 18
2016 15
2017 25
2018 13
2019 22
2020 28
2021 34
2022 25
2023 27
2024 18
2025 21
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

468 results

Results by year

Filters applied: . Clear all
Page 1
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases.
Evans LS, Lewis KE, DeMonte D, Bhandari JG, Garrett LB, Kuijper JL, Ardourel D, Wolfson MF, Debrot S, Mudri S, Kleist K, Griffin LL, Hebb L, Sanderson RJ, Wang N, Seaberg M, Chunyk AG, Yang J, Hong Y, Maria Z, Messenheimer DJ, Holland PM, Peng SL, Rixon MW, Dillon SR. Evans LS, et al. Among authors: dillon sr. Arthritis Rheumatol. 2023 Jul;75(7):1187-1202. doi: 10.1002/art.42462. Epub 2023 Apr 19. Arthritis Rheumatol. 2023. PMID: 36705554
A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.
Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V, Feld M, Alenius H, Dillon SR, Carstens E, Homey B, Basbaum A, Steinhoff M. Cevikbas F, et al. Among authors: dillon sr. J Allergy Clin Immunol. 2014 Feb;133(2):448-60. doi: 10.1016/j.jaci.2013.10.048. Epub 2013 Dec 25. J Allergy Clin Immunol. 2014. PMID: 24373353 Free PMC article.
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
Brevini T, Maes M, Webb GJ, John BV, Fuchs CD, Buescher G, Wang L, Griffiths C, Brown ML, Scott WE 3rd, Pereyra-Gerber P, Gelson WTH, Brown S, Dillon S, Muraro D, Sharp J, Neary M, Box H, Tatham L, Stewart J, Curley P, Pertinez H, Forrest S, Mlcochova P, Varankar SS, Darvish-Damavandi M, Mulcahy VL, Kuc RE, Williams TL, Heslop JA, Rossetti D, Tysoe OC, Galanakis V, Vila-Gonzalez M, Crozier TWM, Bargehr J, Sinha S, Upponi SS, Fear C, Swift L, Saeb-Parsy K, Davies SE, Wester A, Hagström H, Melum E, Clements D, Humphreys P, Herriott J, Kijak E, Cox H, Bramwell C, Valentijn A, Illingworth CJR; UK-PBC Consortium; Dahman B, Bastaich DR, Ferreira RD, Marjot T, Barnes E, Moon AM, Barritt AS 4th, Gupta RK, Baker S, Davenport AP, Corbett G, Gorgoulis VG, Buczacki SJA, Lee JH, Matheson NJ, Trauner M, Fisher AJ, Gibbs P, Butler AJ, Watson CJE, Mells GF, Dougan G, Owen A, Lohse AW, Vallier L, Sampaziotis F. Brevini T, et al. Among authors: dillon s. Nature. 2023 Mar;615(7950):134-142. doi: 10.1038/s41586-022-05594-0. Epub 2022 Dec 5. Nature. 2023. PMID: 36470304 Free PMC article.
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults.
Davies R, Peng SL, Lickliter J, McLendon K, Enstrom A, Chunyk AG, Blanchfield L, Wang N, Blair T, Thomas HM, Smith A, Dillon SR. Davies R, et al. Among authors: dillon sr. Clin Transl Sci. 2024 Nov;17(11):e70055. doi: 10.1111/cts.70055. Clin Transl Sci. 2024. PMID: 39494621 Free PMC article. Clinical Trial.
Prediagnostic plasma proteomics profile for hepatocellular carcinoma.
Zhang X, Zhao L, Ngo LH, Dillon ST, Gu X, Lai M, Simon TG, Chan AT, Giovannucci EL, Libermann TA, Zhang X. Zhang X, et al. Among authors: dillon st. J Natl Cancer Inst. 2024 Aug 1;116(8):1343-1355. doi: 10.1093/jnci/djae079. J Natl Cancer Inst. 2024. PMID: 38688524 Free PMC article.
Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker.
Hirohama D, Abedini A, Moon S, Surapaneni A, Dillon ST, Vassalotti A, Liu H, Doke T, Martinez V, Md Dom Z, Karihaloo A, Palmer MB, Coresh J, Grams ME, Niewczas MA, Susztak K. Hirohama D, et al. Among authors: dillon st. J Am Soc Nephrol. 2023 Jul 1;34(7):1279-1291. doi: 10.1681/ASN.0000000000000141. Epub 2023 Apr 5. J Am Soc Nephrol. 2023. PMID: 37022120 Free PMC article.
Urinary Complement proteome strongly linked to diabetic kidney disease progression.
Md Dom ZI, Moon S, Satake E, Hirohama D, Palmer ND, Lampert H, Ficociello LH, Abedini A, Fernandez K, Liang X, Pickett S, Levinsohn J, O'Neil K, Dillon ST, Mauer M, Galecki AT, Freedman BI, Susztak K, Doria A, Krolewski AS, Niewczas MA. Md Dom ZI, et al. Among authors: dillon st. Nat Commun. 2025 Aug 7;16(1):7291. doi: 10.1038/s41467-025-62101-5. Nat Commun. 2025. PMID: 40775226 Free PMC article.
Pathophysiology of Femoral Fractures in Hypophosphatasia.
Tabegna FGA, Garton M, D'Amore S, Skingle L, Dillon S, Duer MJ, Clunie GPR, Poole KES. Tabegna FGA, et al. Among authors: dillon s. Curr Osteoporos Rep. 2025 Sep 4;23(1):36. doi: 10.1007/s11914-025-00929-y. Curr Osteoporos Rep. 2025. PMID: 40906226 Free PMC article. Review.
468 results